Evidence map›Paper›PMID 33158553›Full record

ArticleJournal of psychiatric research2021

Characteristics of depressed suicide attempters with remitted substance use disorders.

Mina M Rizk, Hanga Galfalvy, Jeffrey M Miller, Matthew Milak, Ramin Parsey, Michael Grunebaum, Ainsley Burke, M Elizabeth Sublette, Maria A Oquendo, Barbara Stanley and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of psychiatric research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Mina M RizkDepartment of Psychiatry, Columbia University Irving Medical Center, Columbia University, New York, NY, USA; Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, USA. Electronic address: mina.rizk@nyspi.columbia.edu.
Hanga GalfalvyDivision of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, USA; Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA.
Jeffrey M MillerDepartment of Psychiatry, Columbia University Irving Medical Center, Columbia University, New York, NY, USA; Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, USA.
Matthew MilakDepartment of Psychiatry, Columbia University Irving Medical Center, Columbia University, New York, NY, USA; Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, USA.
Ramin ParseyDepartment of Psychiatry, Stony Brook University, New York, NY, USA.
Michael GrunebaumDepartment of Psychiatry, Columbia University Irving Medical Center, Columbia University, New York, NY, USA; Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, USA.
Ainsley BurkeDepartment of Psychiatry, Columbia University Irving Medical Center, Columbia University, New York, NY, USA; Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, USA.
M Elizabeth SubletteDepartment of Psychiatry, Columbia University Irving Medical Center, Columbia University, New York, NY, USA; Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, USA.
Maria A OquendoDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Barbara StanleyDepartment of Psychiatry, Columbia University Irving Medical Center, Columbia University, New York, NY, USA; Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, USA.
J John MannDepartment of Psychiatry, Columbia University Irving Medical Center, Columbia University, New York, NY, USA; Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York, NY, USA; Department of Radiology, Columbia University Irving Medical Center, New York, NY, USA.
Columbia University Irving Medical Center · USNew York Psychoanalytic Society and Institute · USStony Brook University · USUniversity of Pennsylvania · US

Funding

Suicidal Behavior: Aggression Subtypes, Childhood Adversity and Stress ResponseP50MH090964 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MANN, JOSEPH JOHN · 2013 to 2022
$23.6M
THE NEUROBIOLOGY OF SUICIDAL BEHAVIORP50MH062185 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MANN, JOSEPH JOHN · 2000 to 2009
$21.7M
Neurobiology of Depression and AntidepressantsR01MH040695 · NIMH · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI MANN, JOSEPH JOHN · 1986 to 2014
$7.1M
Ketamine vs Midazolam: Testing Rapid Relief of Suicide Risk in DepressionR01MH096784 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI GRUNEBAUM, MICHAEL F · 2012 to 2016
$2.8M
Biological Predictors of Response to AntidepressantsR01MH074813 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PARSEY, RAMIN V. · 2006 to 2010
$2.3M
The Antidepressant Action of Ketamine:Brain ChemistryR01MH093637 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MILAK, MATE ISTVAN · 2011 to 2014
$2.3M
The Neurochemistry of Cognitive Therapy: Predicting Treatment Outcome with PETK08MH085061 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MILLER, JEFFREY M · 2010 to 2014
$925k
Neuroimaging of Fatty Acids in Major DepressionK08MH079033 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SUBLETTE, M ELIZABETH · 2008 to 2012
$887k
Paroxetine/Bupropion in Suicide Attempters/Ideators with Major DepressionK23MH076049 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GRUNEBAUM, MICHAEL F · 2006 to 2010
$884k
Novel Mechanisms Underlying Depression: PET Imaging of the Kappa Opioid ReceptorR21MH091553 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MILLER, JEFFREY M · 2011 to 2012
$462k
NIMH NIH HHS K08 MH079033NIMH NIH HHS K08 MH085061NIMH NIH HHS K23 MH076049NIMH NIH HHS P50 MH062185NIMH NIH HHS P50 MH090964NIMH NIH HHS R01 MH040695NIMH NIH HHS R01 MH074813NIMH NIH HHS R01 MH093637NIMH NIH HHS R01 MH096784NIMH NIH HHS R21 MH091553
6 · The paper itself

Abstract

Substance use disorder (SUD) comorbidity in mood disorders increases suicide risk. Suicide attempters with active SUD appear to have distinct characteristics but little is known whether these characteristics persist during remission and if they are related to different aspects of suicidal behavior. In this study, suicide attempters with a DSM mood disorder and remitted SUD (AT+SUD) (N = 135) were compared to those without lifetime SUD (AT-SUD) (N = 219) in terms of demographic, clinical and suicidal behavioral characteristics. Factor analyses were conducted to generate subjective distress and impulsivity/aggression factors - previously identified by our group to predict suicide risk in mood disorders. Associations between these traits and SUD history and suicidal behavior characteristics were then tested. Compared with AT-SUD, AT+SUD were more likely to be male, less educated and to have a Cluster B personality disorder. AT+SUD individuals had greater impulsivity/aggression factor scores, but comparable subjective distress scores. AT+SUD made a greater number of suicide attempts, with higher lethality, despite comparable suicide intent and degree of planning with AT-SUD. Impulsivity/aggression was higher in multiple versus single attempters, but did not correlate with suicide attempt lethality. Among suicide attempters with mood disorders, a history of lifetime SUD was associated with more frequent and more lethal suicide attempts. Among other correlates of lifetime SUD in this sample, impulsive/aggressive traits may explain greater frequency of suicide attempts. The results underscore that persons with mood disorders and lifetime SUD are at particularly high risk of frequent and lethal suicide attempts where more intensive prevention efforts are warranted.

Indexed as

Substance-Related DisordersSuicide, AttemptedAggressionFemaleHumansImpulsive BehaviorMalePersonality DisordersRisk FactorsSuicidal IdeationImpulsivity/aggressionMood disorderSubstance use disorderSuicide

Identifiers

PMID33158553
PMCPMC8084874
OpenAlexW3097446407

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.